Shareholders' Equity (Deficiency)

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Shareholders' Equity (Deficiency)

Shareholders’ Equity (Deficiency)

The following summarizes our shareholders’ equity (deficiency) activity for the three months ended March 31, 2020 and 2019.

(Dollars in Millions)	Par Value of Issued Shares		Capital in Excess of Par Value		Retained Deficit			Accumulated Other Comprehensive Income (Loss)			Non-controlling Interests			Total Shareholders’ Equity (Deficiency)
Balance at December 31, 2019 (Successor)	$	—	$	2,897	$	(26	)	$	9		$	36		$	2,916
Net Income (Loss)	—		—		(966		)	—			8			(958		)
Other Comprehensive Loss	—		—		—			(95		)	—			(95		)
Balance at March 31, 2020 (Successor)	$	—	$	2,897	$	(992	)	$	(86	)	$	44		$	1,863
Balance at December 31, 2018 (Predecessor)	$	1	$	6,711	$	(8,671	)	$	(1,746	)	$	39		$	(3,666	)
Net Income (Loss)	—		—		(481		)	—			4			(477		)
Other Comprehensive Income	—		—		—			33			—			33
Dividends Paid to Noncontrolling Interests	—		—		—			—			(5		)	(5		)
Equity Awards Granted, Vested and Exercised	—		8		—			—			—			8
Other	—		—		—			—			1			1
Balance at March 31, 2019 (Predecessor)	1		6,719		(9,152		)	(1,713		)	39			(4,106		)

The following table presents the changes in our accumulated other comprehensive income (loss) by component for the three months ended March 31, 2020 for the Successor and three months ended March 31, 2019 for the Predecessor:

(Dollars in millions)	Currency Translation Adjustment			Defined Benefit Pension			Deferred Loss on Derivatives			Total
Balance at December 31, 2019 (Successor)	$	7		$	2		$	—		$	9
Other Comprehensive Loss	$	(95	)	$	—		$	—		$	(95	)
Balance at March 31, 2020 (Successor)	$	(88	)	$	2		$	—		$	(86	)
Balance at December 31, 2018 (Predecessor)	$	(1,724	)	$	(14	)	$	(8	)	$	(1,746	)
Other Comprehensive Income	33			—			—			33
Balance at March 31, 2019 (Predecessor)	$	(1,691	)	$	(14	)	$	(8	)	$	(1,713	)